Mycophenolate mofetil and Ankylosing spondylitis - a phase IV clinical study of FDA data

Summary:

Ankylosing spondylitis is reported as a side effect among people who take Mycophenolate mofetil (mycophenolate mofetil), especially for people who are female, 40-49 old, also take Lyrica, and have Rheumatoid arthritis.

The phase IV clinical study analyzes which people have Ankylosing spondylitis when taking Mycophenolate mofetil. It is created by eHealthMe based on reports of 93,176 people who have side effects when taking Mycophenolate mofetil from the FDA, and is updated regularly.

What is Mycophenolate mofetil?

Mycophenolate mofetil has active ingredients of mycophenolate mofetil. It is often used in myasthenia gravis. eHealthMe is studying from 93,461 Mycophenolate mofetil users. Check the latest studies of Mycophenolate mofetil.

What is Ankylosing spondylitis?

Ankylosing spondylitis (type of arthritis affecting the spine) is found to be associated with 743 drugs and 1,049 conditions by eHealthMe. Check the latest studies of Ankylosing spondylitis.

On Aug, 05, 2026

93,176 people reported to have side effects when taking Mycophenolate mofetil.
Among them, 59 people (0.06%) have Ankylosing spondylitis.

Could Mycophenolate mofetil cause Ankylosing spondylitis?

Among these 59 people:

What is the gender of people who have Ankylosing spondylitis when taking Mycophenolate mofetil? *

female: 91.07 %
male: 8.93 %

What is the age of people who have Ankylosing spondylitis when taking Mycophenolate mofetil? *

What are other drugs people take besides Mycophenolate mofetil? *

What are other side effects people have besides Ankylosing spondylitis? *

Nausea (feeling of having an urge to vomit): 50 people, 84.75%
Weakness: 47 people, 79.66%
Fatigue (feeling of tiredness): 47 people, 79.66%
Hypersensitivity: 47 people, 79.66%
Synovitis (inflammation of the synovial membrane): 47 people, 79.66%
Joint Swelling: 47 people, 79.66%
Joint Pain: 47 people, 79.66%
Pain: 46 people, 77.97%
Rashes (redness): 46 people, 77.97%
Musculoskeletal Stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves): 46 people, 77.97%

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 41 people, 69.49%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 39 people, 66.10%
Psoriasis (immune-mediated disease that affects the skin): 29 people, 49.15%
Fibromyalgia (a long-term condition which causes pain all over the body): 13 people, 22.03%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 9 people, 15.25%
Headache (pain in head): 8 people, 13.56%
Synovitis (inflammation of the synovial membrane): 6 people, 10.17%
Stress And Anxiety: 6 people, 10.17%
Pemphigus (any of several acute or chronic skin diseases characterized by groups of itching blisters): 6 people, 10.17%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 5 people, 8.47%

* Approximation only. Some reports may have incomplete information.

Do you take Mycophenolate mofetil and have Ankylosing spondylitis?

- Check whether Ankylosing spondylitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Mycophenolate mofetil:

Mycophenolate mofetil (93,461 reports)

Browse all side effects of Mycophenolate mofetil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Ankylosing spondylitis:

Ankylosing spondylitis (743 drugs)

Browse all the conditions that are associated with Ankylosing spondylitis:

Ankylosing spondylitis (1,049 conditions)

Related publications that referenced our studies

Hung YM, Cheng CC, Wann SR, Lin SL, "Ankylosing spondylitis associated with pulmonary arterial hypertension", Internal Medicine, 2016 Jan .
Hung YM, Cheng CC, Wann SR, Lin SL, "Ankylosing spondylitis associated with pulmonary arterial hypertension", Internal Medicine, 2016 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on mycophenolate mofetil (the active ingredients of Mycophenolate mofetil) and Mycophenolate mofetil (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.